Investing-News.Com
Information for Investors

CV THERAPEUTICS I, (CVTX) Stock Ratings - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

CV THERAPEUTICS I, (CVTX) Stock Rating Learn More

Our Overall Rating on CV Therapeutics Inc,  CVTX is BUY
StockPickReport.Com research suggests CVTX's price will move significantly higher than the "open price" the day this rating was initiated.

This analysis is based on short-term stochastic and "relative strength" indicators.

Both stochastic and "relative strength" indicators point to a move up.

Investors, traders, and other market participants may find this a good opportunity to buy CVTX, "buy calls", or "sell puts".

This may also be an opportunity to raise targets and stop/losses to allow for potential gains.

Trading volume seems to be falling and CVTX's closing price moved up during the week before this rating was initiated.

Our BUY Rating on CVTX was issued on 03/25/08

CV THERAPEUTICS I Technical Rating



Ratings Provided by Stock-Letter-Daily.Com

Rate Any Stock
(enter symbol and click)

Stock Rating Definitions

Stock Ratings Home

Sponsored Links:

Software Forces CV THERAPEUTICS I Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in CV THERAPEUTICS I buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on CV THERAPEUTICS I. This software is specially designed to give precision entry and exit points on CV THERAPEUTICS I, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When CV THERAPEUTICS I Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even CV THERAPEUTICS I, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: penny stock advisor  vanguard emerging market stock index ireland-domiciled investments  stock trading software 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350 (Marketwire)

New Emerging Biotech and Pharma Company Index (at Seeking Alpha)

[$$] Biotech Mailbag: Recap on GenVec (at RealMoney by TheStreet.com)

9 Things You Should Do Instead of Buying Stocks (at Motley Fool)

CV Therapeutics, Inc. Q3 2008 Earnings Call Transcript (at Seeking Alpha)

CV THERAPEUTICS INC Financials (EDGAR Online Financials)

Rigel Pharmaceuticals: Biotech Crisis or Opportunity? (at Seeking Alpha)

New Star Analyst Rankings for CV THERAPEUTICS I (StarMine)

Stocks to Avoid Now? (at Motley Fool)

CV THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.